- Home
- ORMP vs BANX Comparison
ORMP vs BANX Comparison
Compare ORMP & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | BANX |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 154.9M |
| IPO Year | 2010 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ORMP | BANX |
|---|---|---|
| Price | $3.32 | $19.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 164.3K | 68.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $1,340,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.82 | $17.99 |
| 52 Week High | $3.76 | $23.67 |
Technical Indicators
Market Signals| Indicator | ORMP | BANX |
|---|---|---|
| Relative Strength Index (RSI) | 48.48 | 35.57 |
| Support Level | $3.22 | N/A |
| Resistance Level | $3.76 | $20.93 |
| Average True Range (ATR) | 0.20 | 0.27 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 28.57 | 52.63 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.